U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation
17.06.2022 - DENVER, June 17, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology aiming to transform the treatment of mental health and addiction disorders, today announced ... Seite 1